Chukwumezie Beatrice Nkem, Wojcik Mark, Malak Paul, Adeyeye Moji Christianah
Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA.
AAPS PharmSciTech. 2002;3(1):E2. doi: 10.1208/pt030102.
The aim of this study was to develop spheronized microparticulates as a drug delivery system using the 1-step closed rotor disk fluid-bed technology, and to scale up the batch spheronization process. Ibuprofen was used as the model drug and microcrystalline cellulose/sodium carboxymethyl cellulose hydrocolloid (Avicel(R) RC-581 or CL-611) was present as the diluent/binder. The mixture, in 1:1 ratio, was blended with and without 1% sodium lauryl sulfate (SLS) and spheronized with the rotor disk insert, using either water or hydroxypropylmethyl cellulose (HPMC) as binder. Fluid-bed machines (Vector/Freund Flo-Coater model) FLM-1 (with 9-inch rotor insert for 0.75 kg) and FLM-15 (with a 12-inch and 19-inch rotor inserts for 1 kg and 5, 10 kg, respectively) were used. The critical process parameters included inlet air temperature, rotor disk speed and configuration, air flow, and rate of binder application. The 1 kg batch containing SLS that was made with 12-inch smooth stainless steel or waffle teflon plates rotating at 500 rpm had desirable characteristics. The sphericity values were 0.88 and 0.91, with percent yield of 85.4 and 91.2 and drug content values of 94.47% and 91.44%, respectively. The spheroids showed good flow properties with respective rapid drug release (Q20 = 83.27 and 91.75). No difference was seen in the Avicel RC-581 and CL-611. Based on the 1 kg data, Avicel RC-581 and smooth stainless steel and waffle teflon plates (12 inch and 19 inch), the batch was scaled up to 5 and 10 kg. The scale-up parameters included rotor speed (124 -300 rpm) and spray rate (90-140 g/min). The scale-up batches had similar flow characteristics, release rate, and size distribution. The geometric mean diameter increased as batch size increased, and slightly bigger spheroids were obtained using the waffle teflon plate. Ibuprofen spheres with very good physical characteristics were developed using the rotor disk fluid-bed technology, a 1-step closed process that did not require additional unit processes.
本研究的目的是利用一步法密闭转子盘流化床技术开发球形化微粒作为药物递送系统,并扩大批量球形化工艺。以布洛芬为模型药物,以微晶纤维素/羧甲基纤维素钠水胶体(Avicel® RC - 581或CL - 611)作为稀释剂/黏合剂。将该混合物按1:1比例混合,添加和不添加1%十二烷基硫酸钠(SLS),并使用转子盘插件进行球形化处理,分别以水或羟丙基甲基纤维素(HPMC)作为黏合剂。使用了流化床机器(Vector/Freund Flo - Coater型号)FLM - 1(配备用于0.75 kg的9英寸转子插件)和FLM - 15(分别配备用于1 kg、5 kg和10 kg的12英寸和19英寸转子插件)。关键工艺参数包括进气温度、转子盘速度和配置、气流以及黏合剂施加速率。用12英寸光滑不锈钢板或华夫格特氟龙板在500 rpm转速下制备的含SLS的1 kg批次具有理想的特性。球形度值分别为0.88和0.91,产率分别为85.4%和91.2%,药物含量分别为94.47%和91.44%。这些球体显示出良好的流动特性以及各自快速的药物释放(Q20 = 83.27和91.75)。在Avicel RC - 581和CL - 611之间未观察到差异。基于1 kg的数据、Avicel RC - 581以及光滑不锈钢板和华夫格特氟龙板(12英寸和19英寸),将批次扩大至5 kg和10 kg。放大参数包括转子速度(124 - 300 rpm)和喷雾速率(90 - 140 g/min)。放大后的批次具有相似的流动特性、释放速率和粒度分布。几何平均直径随着批次大小的增加而增大,并且使用华夫格特氟龙板可获得稍大的球体。使用转子盘流化床技术开发出了具有非常良好物理特性的布洛芬球体,这是一种一步法密闭工艺,无需额外的单元工艺。